SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress
Abstract The COVID-19 pandemic resulting from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which emerged in December 2019 in Wuhan in China has placed immense burden on national economies and global health. At present neither vaccination nor therapies are available. Here, we perf...
Guardado en:
Autores principales: | Wasco Wruck, James Adjaye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e6d25390142476098ac5f7cee795cb3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry
por: Anna Goc, et al.
Publicado: (2021) -
The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Yanqiu Gong, et al.
Publicado: (2021) -
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
por: Seiya Ozono, et al.
Publicado: (2021) -
The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zengyuan Zhang, et al.
Publicado: (2021) -
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Christopher J. Day, et al.
Publicado: (2021)